Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-17 5:16 pm Purchase | 2021-05-06 | 13G | Shattuck Labs, Inc. STTK | EcoR1 Capital, LLC | 3,295,088 7.900% | 3,295,088 (New Position) | Filing History |
| 2021-05-11 4:08 pm Purchase | 2021-05-04 | 13D | AnaptysBio, Inc. ANAB | EcoR1 Capital, LLC | 7,520,424 27.500% | 368,800 (+5.16%) | Filing History |
| 2021-05-11 4:06 pm Purchase | 2021-05-04 | 13G | Corvus Pharmaceuticals, Inc. CRVS | EcoR1 Capital, LLC | 3,579,377 8.500% | 3,579,377 (New Position) | Filing History |
| 2021-04-12 5:45 pm Unchanged | 2021-04-08 | 13D | AnaptysBio, Inc. ANAB | EcoR1 Capital, LLC | 7,151,624 26.100% | 0 (Unchanged) | Filing History |
| 2021-03-10 5:17 pm Purchase | 2021-03-08 | 13D | AnaptysBio, Inc. ANAB | EcoR1 Capital, LLC | 7,151,624 26.100% | 3,338,300 (+87.54%) | Filing History |
| 2021-02-16 12:16 pm Sale | 2020-12-31 | 13G | Surface Oncology, Inc. SURF | EcoR1 Capital, LLC | 48,558 0.100% | -4,985,303 (-99.04%) | Filing History |
| 2021-02-16 12:11 pm Purchase | 2020-12-31 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital, LLC | 531,847 9.400% | 180,180 (+51.24%) | Filing History |
| 2021-02-16 12:10 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital, LLC | 2,103,950 5.600% | 2,103,950 (New Position) | Filing History |
| 2021-02-16 12:07 pm Purchase | 2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital, LLC | 3,092,218 8.700% | 450,000 (+17.03%) | Filing History |
| 2021-02-16 12:05 pm Sale | 2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | EcoR1 Capital, LLC | 156,135 7.500% | -39,659 (-20.26%) | Filing History |
| 2021-02-16 12:02 pm Purchase | 2020-12-31 | 13G | Morphic Holding, Inc. MORF | EcoR1 Capital, LLC | 2,839,884 9.100% | 685,039 (+31.79%) | Filing History |
| 2021-02-16 12:00 pm Sale | 2020-12-31 | 13G | Kura Oncology, Inc. KURA | EcoR1 Capital, LLC | 1,773,037 2.700% | -2,468,916 (-58.20%) | Filing History |
| 2021-02-16 11:58 am Sale | 2020-12-31 | 13G | Geron Corporation GERN | EcoR1 Capital, LLC | 28,555,310 8.900% | -290,844 (-1.01%) | Filing History |
| 2021-02-16 11:56 am Purchase | 2020-12-31 | 13G | Atreca, Inc. BCEL | EcoR1 Capital, LLC | 2,426,685 8.100% | 945,274 (+63.81%) | Filing History |
| 2021-02-16 11:54 am Purchase | 2020-12-31 | 13G | Akouos, Inc. AKUS | EcoR1 Capital, LLC | 1,975,984 5.700% | 1,975,984 (New Position) | Filing History |
| 2021-02-16 09:49 am Unchanged | 2020-12-31 | 13G | Savara Inc. SVRA | EcoR1 Capital, LLC | 3,040,540 5.300% | 0 (Unchanged) | Filing History |
| 2021-02-12 5:48 pm Sale | 2020-12-31 | 13G | Savara Inc. SVRA | EcoR1 Capital, LLC | 3,040,540 5.300% | -1,432,664 (-32.03%) | Filing History |
| 2021-02-12 5:33 pm Sale | 2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | EcoR1 Capital, LLC | 20,000 3.600% | -13,847 (-40.91%) | Filing History |
| 2021-02-12 5:23 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | EcoR1 Capital, LLC | 93,416 0.200% | -2,235,076 (-95.99%) | Filing History |
| 2021-02-12 5:19 pm Sale | 2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | EcoR1 Capital, LLC | 76,628 2.100% | -153,257 (-66.67%) | Filing History |